Fistula-associated anal carcinoma in Crohn’s disease

References

• Jess T, Gamborg M, Matzen P, et al. Increased risk of intestinal cancer in Crohn’s disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol. 2005;100(12):2724–2729.
   PubMed Web of Science ®Google Scholar
• Canavan C, Abrams KR, Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn’s disease. Aliment Pharmacol Ther. 2006;23(8):1097–1104.
   PubMed Web of Science ®Google Scholar
• Daly JJ, Madrazo A. Anal Crohn’s disease with carcinoma in situ. Dig Dis Sci. 1980;25(6):464–466.
   PubMed Web of Science ®Google Scholar
• Chaikhouni A, Regueyra FI, Stevens JR. Adenocarcinoma in perineal fistulas of Crohn’s disease. Dis Colon Rectum. 1981;24(8):639–643.
   PubMed Web of Science ®Google Scholar
• Preston DM, Fowler EF, Lennard-Jones JE, et al. Carcinoma of the anus in Crohn’s disease. Br J Surg. 1983;70(6):346–347.
   PubMed Web of Science ®Google Scholar
• Slater G, Greenstein A, Aufses AH Jr. Anal carcinoma in patients with Crohn’s disease. Ann Surg. 1984;199(3):348–350.
   PubMed Web of Science ®Google Scholar
• Church JM, Weakley FL, Fazio VW, et al. The relationship between fistulas in Crohn’s disease and associated carcinoma. Report of four cases and review of the literature. Dis Colon Rectum. 1985;28(5):361–366.
   PubMed Web of Science ®Google Scholar
• Nelson RL, Prasad ML, Abcarian H. Anal carcinoma presenting as a perirectal abscess or fistula. Arch Surg. 1985;120(5):632–635.
   PubMedGoogle Scholar
• Ball CS, Wujanto R, Haboubi NY, et al. Carcinoma in anal Crohn’s disease: discussion paper. J R Soc Med. 1988;81(4):217–219.
   PubMed Web of Science ®Google Scholar
• Lumley JW, Stitz RW. Crohn’s disease and anal carcinoma: an association? A case report and review of the literature. Aust N Z J Surg. 1991;61(1):76–77.
   PubMedGoogle Scholar
• Buchman AL, Ament ME, Doty J. Development of squamous cell carcinoma in chronic perineal sinus and wounds in Crohn’s disease. Am J Gastroenterol. 1991;86(12):1829–1832.
   PubMed Web of Science ®Google Scholar
• Connell WR, Sheffield JP, Kamm MA, et al. Lower gastrointestinal malignancy in Crohn’s disease. Gut. 1994;35(3):347–352.
   PubMed Web of Science ®Google Scholar
• Nikias G, Eisner T, Katz S, et al. Crohn’s disease and colorectal carcinoma: rectal cancer complicating longstanding active perianal disease. Am J Gastroenterol. 1995;90(2):216–219.
   PubMed Web of Science ®Google Scholar
• Ky A, Sohn N, Weinstein MA, et al. Carcinoma arising in anorectal fistulas of Crohn’s disease. Dis Colon Rectum. 1998;41(8):992–996.
   PubMed Web of Science ®Google Scholar
• Vernava AM 3rd. Cancer in chronic perianal fistulas of Crohn’s disease. Dis Colon Rectum. 1999;42(2):282–283.
   PubMed Web of Science ®Google Scholar
• Kulaylat MN, Gallina G, Bem J, et al. Carcinoma arising in anorectal fistulas of Crohn’s disease. Dis Colon Rectum. 1999;42(6):826–828.
   PubMed Web of Science ®Google Scholar
• Korelitz BI. Carcinoma arising in Crohn’s disease fistulae: another concern warranting another type of surveillance. Am J Gastroenterol. 1999;94(9):2337–2339.
   PubMed Web of Science ®Google Scholar
• Wong NA, Shirazi T, Hamer-Hodges DW, et al. Adenocarcinoma arising within a Crohn’s-related anorectal fistula: a form of anal gland carcinoma?. Histopathology. 2002;40(3):302–304.
   PubMed Web of Science ®Google Scholar
• Kuhlgatz J, Golas MM, Sander B, et al. Human papilloma virus infection in a recurrent squamous cell carcinoma associated with severe Crohn’s disease. Inflamm Bowel Dis. 2005;11(1):84–86.
   PubMed Web of Science ®Google Scholar
• Kazama S, Hiramatsu T, Kobayashi R, et al. Cancer in the anal canal, and in an anal fistula, that developed during a longstanding course of Crohn’s disease. J Gastroenterol. 2005;40(10):1000–1001.
   PubMed Web of Science ®Google Scholar
• Gaertner WB, Hagerman GF, Finne CO, et al. Fistula-associated anal adenocarcinoma: good results with aggressive therapy. Dis Colon Rectum. 2008;51(7):1061–1067.
   PubMed Web of Science ®Google Scholar
• Devon KM, Brown CJ, Burnstein M, et al. Cancer of the anus complicating perianal Crohn’s disease. Dis Colon Rectum. 2009;52(2):211–216.
   PubMed Web of Science ®Google Scholar
• Iesalnieks I, Gaertner WB, Glass H, et al. Fistula-associated anal adenocarcinoma in Crohn’s disease. Inflamm Bowel Dis. 2010;16(10):1643–1648.
   PubMed Web of Science ®Google Scholar
• Alcalde-Vargas A, Trigo-Salado C, Leo-Carnerero E, et al. Severe perianal disease degenerated to adenocarcinoma. Is close monitoring of long-term perianal disease necessary?. Rev Esp Enferm Dig. 2013;105(2):115–116.
   PubMed Web of Science ®Google Scholar
• Ogawa H, Haneda S, Shibata C, et al. Adenocarcinoma associated with perianal fistulas in Crohn’s disease. Anticancer Res. 2013;33(2):685–689.
   PubMed Web of Science ®Google Scholar
• Sogawa M, Watanabe K, Egashira Y, et al. Precise endoscopic and pathologic features in a Crohn’s disease case with two fistula-associated small bowel adenocarcinomas complicated by an anal canal adenocarcinoma. Intern Med. 2013;52(4):445–449.
   PubMed Web of Science ®Google Scholar
• Benjelloun EB, Abkari M, Ousadden A, et al. Squamous cell carcinoma associated anal fistulas in Crohn’s disease unique case report with literature review. J Crohns Colitis. 2013;7(6):e232–e235.
   PubMedGoogle Scholar
• Papaconstantinou I, Mantzos DS, Kondi-Pafiti A, et al. Anal adenocarcinoma complicating chronic Crohn’s disease. Int J Surg Case Rep. 2015;10:201–203.
   PubMed Web of Science ®Google Scholar
• Maejima T, Kono T, Orii F, et al. Anal canal adenocarcinoma in a patient with longstanding Crohn’s disease arising from rectal mucosa that migrated from a previously treated rectovaginal fistula. Am J Case Rep. 2016;17:448–453.
   PubMed Web of Science ®Google Scholar
• Shwaartz C, Munger JA, Deliz JR, et al. Fistula-associated anorectal cancer in the setting of Crohn’s disease. Dis Colon Rectum. 2016;59(12):1168–1173.
   PubMed Web of Science ®Google Scholar
• Lightner AL, Moncrief SB, Smyrk TC, et al. Long-standing Crohn’s disease and its implication on anal squamous cell cancer management. Int J Colorectal Dis. 2017;32(5):661–666.
   PubMed Web of Science ®Google Scholar
• Beaugerie L, Carrat F, Nahon S, et al. Cancers et Surrisque Associé aux Maladies Inflammatoires Intestinales En France Study Group. High risk of anal and rectal cancer in patients with anal and/or perianal Crohn’s disease. Clin Gastroenterol Hepatol. 2018;16(6):892–899.
   PubMedGoogle Scholar
• Thomas M, Bienkowski R, Vandermeer TJ, et al. Malignant transformation in perianal fistulas of Crohn’s disease: a systematic review of literature. J Gastrointest Surg. 2010;14(1):66–73.
   PubMed Web of Science ®Google Scholar
• Ruel J, Ko HM, Roda G, et al. Anal neoplasia in inflammatory bowel disease is associated with HPV and perianal disease. Clin Transl Gastroenterol. 2016;7:e148.
   PubMed Web of Science ®Google Scholar
• Slesser AA, Bhangu A, Bower M, et al. A systematic review of anal squamous cell carcinoma in inflammatory bowel disease. Surg Oncol. 2013;22(4):230–237.
   PubMed Web of Science ®Google Scholar
• Shiels MS, Kreimer AR, Coghill AE, et al. Anal cancer incidence in the United States, 1977–2011: distinct patterns by histology and behavior. Cancer Epidemiol Biomarkers Prev. 2015;24(10):1548–1556.
   PubMed Web of Science ®Google Scholar
• Daling JR, Sherman KJ, Hislop TG, et al. Cigarette smoking and the risk of anogenital cancer. Am J Epidemiol. 1992;135(2):180–189.
   PubMed Web of Science ®Google Scholar
• Lavery IC, Jagelman DG. Cancer in the excluded rectum following surgery for inflammatory bowel disease. Dis Colon Rectum. 1982;25(6):522–524.
   PubMed Web of Science ®Google Scholar
• Argollo M, Fiorino G, Hindryckx P, et al. Novel therapeutic targets for inflammatory bowel disease. J Autoimmun. 2017;85:103–116.
   PubMed Web of Science ®Google Scholar
• Weimers P, Munkholm P. The natural history of IBD: lessons learned. Curr Treat Options Gastroenterol. 2018;16(1):101–111.
   PubMedGoogle Scholar
• Malvi D, Vasuri F, Mattioli B, et al. Adenocarcinoma in Crohn’s disease: the pathologist’s experience in a tertiary referral centre of inflammatory bowel disease. Pathology. 2014;46(5):439–443.
   PubMed Web of Science ®Google Scholar
• Williams CJ, Peyrin-Biroulet L, Ford AC. Systematic review with meta-analysis: malignancies with anti-tumour necrosis factor-α therapy in inflammatory bowel disease. Aliment Pharmacol Ther. 2014;39(5):447–458.
   PubMed Web of Science ®Google Scholar
• Bonovas S, Minozzi S, Lytras T, et al. Risk of malignancies using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis. Expert Opin Drug Saf. 2016;15(sup1):35–54.
   PubMed Web of Science ®Google Scholar
• Bonovas S, Fiorino G, Allocca M, et al. Biologic therapies and risk of infection and malignancy in patients with inflammatory bowel disease: a systematic review and network meta-analysis. Clin Gastroenterol Hepatol. 2016;14(10):1385–1397.
   PubMed Web of Science ®Google Scholar
• Chaparro M, Ramas M, Benítez JM, et al. Extracolonic cancer in inflammatory bowel disease: data from the GETECCU Eneida Registry. Am J Gastroenterol. 2017;112(7):1135–1143.
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Allan RN, Keighley MR. Effect of fecal diversion alone on perianal Crohn’s disease. World J Surg. 2000;24(10):1258–1262.
   PubMed Web of Science ®Google Scholar
• Lad SV, Haider MA, Brown CJ, et al. MRI appearance of perianal carcinoma in Crohn’s disease. J Magn Reson Imaging. 2007;26(6):1659–1662.
   PubMed Web of Science ®Google Scholar
• Brochard C, Siproudhis L, Wallenhorst T, et al. Anorectal stricture in 102 patients with Crohn’s disease: natural history in the era of biologics. Aliment Pharmacol Ther. 2014;40(7):796–803.
   PubMed Web of Science ®Google Scholar
• Bemelman WA, Warusavitarne J, Sampietro GM, et al. ECCO-ESCP consensus on surgery for Crohn’s disease. J Crohns Colitis. 2018;12(1):1–16.
   PubMed Web of Science ®Google Scholar
• Nishigami T, Kataoka TR, Ikeuchi H, et al. Adenocarcinomas associated with perianal fistulae in Crohn’s disease have a rectal, not an anal, immunophenotype. Pathology. 2011;43(1):36–39.
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Keighley MR. Proctocolectomy is associated with a higher complication rate but carries a lower recurrence rate than total colectomy and ileorectal anastomosis in Crohn colitis. Scand J Gastroenterol. 1999;34(12):1212–1215.
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Allan RN, Keighley MR. Audit of single-stage proctocolectomy for Crohn’s disease: postoperative complications and recurrence. Dis Colon Rectum. 2000;43(2):249–256.
   PubMed Web of Science ®Google Scholar
• Sengul N, Wexner SD, Woodhouse S, et al. Effects of radiotherapy on different histopathological types of rectal carcinoma. Colorectal Dis. 2006;8(4):283–288.
   PubMed Web of Science ®Google Scholar
• Nigro ND, Vaitkevicius VK, Buroker T, et al. Combined therapy for cancer of the anal canal. Dis Colon Rectum. 1981;24(2):73–75.
   PubMed Web of Science ®Google Scholar